🎤 G. Sundar ‎ | 📅 Recording Available | 🕒 90 Minutes
Description:
21 CFR 211.160(b) outlines the FDA's requirement for pharmaceutical manufacturers to establish laboratory controls, including specifications and test procedures, to ensure product quality and safety. Laboratory controls encompass establishing specifications and test procedures, critical for verifying the identity, strength, quality, and purity of pharmaceutical products. These controls serve as a quality assurance framework, governing the entire product lifecycle from raw materials to finished products, playing a pivotal role in regulatory compliance and patient safety.
Recent investigations and warning letters have increasingly targeted laboratory controls due to their substantial impact on product quality and patient safety. These controls have emerged in the top 5 most common observation by regulatory agencies since 2016. The heightened scrutiny is primarily driven by concerns related to data integrity, inadequate testing methodologies, and deviations from established procedures, all of which can compromise the reliability and accuracy of drug quality assessments.
Learning to establish scientifically sound laboratory controls is of paramount importance for pharmaceutical companies. Sound laboratory controls are inherently linked to data integrity, as they safeguard against data manipulation and ensure the accuracy, reliability, and traceability of testing results. This webinar holds great significance as it not only covers the regulatory aspects but also provides real-world case studies, offering practical insights and strategies for pharmaceutical professionals to enhance their laboratory controls, meet compliance requirements, and uphold product quality and patient safety standards.
Learning Objectives:
By the end of this training course, participants will be able to:
Who Should Attend: